Toward Minimal Residual Disease-Directed Therapy in Melanoma

New research in Cell tackles the biology of minimal residual disease (MRD) – the small number of cancer cells remaining after treatment – to identify key drivers of therapeutic resistance. Confocal imaging was performed using a Nikon A1 system

Learn More @ Cell

Recent News and Updates

See all News

Share this article: